We see it as being inferior to what Liponine can do, and this is a function of concentration of Berberine, for the most part, being the primary ingredient of the Liponine coupled with a technological adjunct to increase the bioavailability. The other ingredients in Glucocil have supportive benefits but the sum total of the impact will not be as great, and thus it looks better on the surface, being more comprehensive in potential coverage, in bringing to bear a wider array of ingredients with varying mechanisms that are potentially of value. This is more a hodgepodge without deep understanding of how best to combine them and to what extent they need to be present, with respect to their concentration levels, in order to have maximum effectiveness. So this is a kind of shotgun approach with little deep understanding of how to make an ideal nutraceutical composite. After all, it would not even be possible to carry out all the clinical studies needed to look at 27 ingredients, both alone and in combination with all the permutations, in order to map out what is doing what to whom, in respect to all potential interactions and potential synergies that could be exploited in order to optimize that happening, in balancing the ingredients appropriately. So this is a well-meaning offering but does fall short.
Please login or Register to submit your answer